advertisement
Age and sex significantly influence the risk for developing glaucoma and other age-related blinding conditions, such as age-related macular degeneration, yet pathophysiology of eye aging is not well understood.1
Pathophysiology of eye aging is not well understoodLikewise, it is not known if an aging process differs between men and women. As an age-related neurodegeneration, primary open-angle glaucoma (POAG) is also considered accelerated optic nerve aging because the glaucomatous optic nerve shares both immunohistochemical and clinical characteristics, similar to aging. Evidently, they both exhibit reactive products from an oxidative stress2 and a characteristic pattern of neuroretinal rim loss in the inferotemporal region.3 In addition, the risk of POAG in women is affected not only by chronological age, but also by advancing reproductive age and lifetime exposure to estrogens.4 Recognized the critical effects of the biological sex on aging eye conditions, such as POAG and retinal diseases, Du et al. investigated sex differences in aging. By comparing retinal gene expression responses in female and male C57BL/6JN mice, aged 3 and 24 months, they demonstrated retinal sex differences throughout a mouse lifespan. Notably, while common gene expression exists, as anticipated, the gene expression responses to aging indeed predominantly differ between male and female mice. They further hypothesized that the sexually divergent gene expression throughout life is likely the effects of sex hormones on the retina. Specifically, sex hormones could potentially affect cell function and gene regulation through estrogen, androgen, and non-estrogen receptors within the retina and the retinal pigment epithelium. This observed sexually divergent gene expression responses to aging certainly warrants further investigations. Most importantly, these findings highlight an urgent need to include both sexes in pre-clinical and clinical research. Considering both sexes in aging research will subsequently lead to better understanding of likely interactions between the effects of age and sex on various age-related blinding conditions.